Yinghe Medical
Multimodal medical imaging foundation model and hospital radiology AI suite
About Yinghe Medical
Shanghai Yinghe Yimai Intelligent Technology Co., Ltd. operates at the intersection of artificial intelligence and medical diagnostics, focusing on the development and integration of medical imaging AI. The firm provides imaging doctors with assistive tools based on AI and statistical analysis. A core part of its strategy is the creation of a national-level platform for sharing standardized medical imaging data.
The company's business model revolves around creating AI-driven products tailored to specific medical examination projects. This is achieved by organizing research and development units led by imaging or clinical doctors, who are supported by data and algorithm engineers. The primary objective is to systematically produce AI tools that generate the structured reports needed for various examination types. This approach leverages large-scale data and proprietary multimodal medical imaging models as key operational elements.
Through its work, the company aims to enhance the efficiency and accuracy of medical imaging analysis. The platform facilitates collaboration between medical professionals and technology experts to develop solutions that directly address clinical needs. By building a comprehensive data-sharing platform, Shanghai Yinghe Yimai contributes to the broader medical AI ecosystem, enabling more advanced research and development in the field.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- China
- Open positions
- None listed
- Dealroom signal
- 18.7/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Radiology, Medical Imaging, Core AI, Medical Data, AI for medical imaging, AI Applications, DT and LS
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Oct 2025 | $14M | $55M | Rimag | ↗ |
| SERIES A✓Equity / VC | Apr 2025 | $14M | $55M | CICC · Marathon Venture Partners | ↗ |
Growth signals
Latest recorded traffic for Yinghe Medical is 800 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- MPMarathon Venture Partners
CICC
Rimag
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Yinghe Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Yinghe Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







